ライフサイエンスコーパス: treatment strategy

1 r walking capacity compared to a noninvasive treatment strategy.

2 This is the optimal, cost-effective CDI treatment strategy.

3 egeneration after TBI, along with a putative treatment strategy.

4 this important but complex adjunctive cancer treatment strategy.

5 not be a reason to abandon a pharmacological treatment strategy.

6 facilitates efficient targeted therapies and treatment strategies.

7 n unexpected ways to rapidly inform emerging treatment strategies.

8 ght has been utilized to create new targeted treatment strategies.

9 disorders, that could inform prevention and treatment strategies.

10 which adds exciting opportunities for novel treatment strategies.

11 ify targets for existing repurposed or novel treatment strategies.

12 ich can be exploited to design such targeted treatment strategies.

13 ell as other aetiologies that have different treatment strategies.

14 nities in order to develop innovative cancer treatment strategies.

15 ave shown improved outcomes with neoadjuvant treatment strategies.

16 ns is crucial for designing more sustainable treatment strategies.

17 ceptual basis for development of alternative treatment strategies.

18 de therapeutic window for anticipated future treatment strategies.

19 patients who would benefit from alternative treatment strategies.

20 for the development of new anti-inflammatory treatment strategies.

21 ts for the development of new prevention and treatment strategies.

22 veloping effective diagnosis, prognosis, and treatment strategies.

23 deficits in AN and provides context for new treatment strategies.

24 5 ambulatory visits include nonpharmacologic treatment strategies.

25 identifying patient subgroups and suggesting treatment strategies.

26 lso to the discovery of novel biomarkers and treatment strategies.

27 term clinical outcomes and potentially guide treatment strategies.

28 stratification and optimize surveillance and treatment strategies.

29 This time in the realm of treatment strategies.

30 pression and drug-response would help tailor treatment strategies.

31 an important factor for cancer detection and treatment strategies.

32 tic targets contributing to personalized T2D treatment strategies.

33 role might lead to new cancer prevention and treatment strategies.

34 ons, animal models are needed to develop new treatment strategies.

35 tiology is required to inform prevention and treatment strategies.

36 n that will lead to the development of novel treatment strategies.

37 esis of congenital disease will guide future treatment strategies.

38 luences the addiction process suggests novel treatment strategies.

39 dly deployed to investigate patient-specific treatment strategies.

40 lities for the development of more selective treatment strategies.

41 derstanding COVID-19 pathogenesis and future treatment strategies.

42 severity classification, and preventive and treatment strategies.

43 PET/CT imaging is warranted to guide salvage treatment strategies.

44 ont of the development of novel immune-based treatment strategies.

45 t tumor types will help to develop effective treatment strategies.

46 ive, pharmacological and non-pharmacological treatment strategies.

47 e the differences in management and optimise treatment strategies.

48 useful for development of cisplatin-related treatment strategies.

49 the development of effective prevention and treatment strategies.

50 r and for the development of pharmacological treatment strategies.

51 tionale for the development of UTUC-specific treatment strategies.

52 dict individual tumour behaviour and support treatment strategies.

53 re targeted approaches for weight management treatment strategies.

54 pathological processes that require improved treatment strategies.

55 ving the accuracy of prognosis and design of treatment strategies.

56 well as on its presentation and appropriate treatment strategies.

57 nderstanding disease etiology, and improving treatment strategies.

58 more accurate drug design and more effective treatment strategies.

59 lp to identify its neural substrates and new treatment strategies.

60 ns to enhance subtype-specific diagnoses and treatment strategies.

61 isms of virus-induced brain dysfunction, and treatment strategies.

62 ferent prognoses and might require different treatment strategies.

63 ratification and potentially identifying new treatment strategies.

64 igate the biology of ACC and to identify new treatment strategies.

65 point immunotherapy is key to developing new treatment strategies.

66 uits and provide new insights into potential treatment strategies.

67 able references for clinicians to decide the treatment strategies.

68 to treatment will be key to further improve treatment strategies.

69 ective tailoring of perfusion pressure-based treatment strategies.

70 ation into pathophysiological mechanisms and treatment strategies.

71 CS and to the influence of sex on different treatment strategies.

72 es are needed to enhance early detection and treatment strategies.

73 informative for development of novel cancer treatment strategies.

74 the development and assessment of analgesic treatment strategies.

75 ho had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative

76 h combination was determined for 3 different treatment strategies: a standard treatment (4 cycles of

77 nterference (RNAi) has emerged as a powerful treatment strategy across a potentially broad range of d

78 e data confirm CXCR4 blockade as a promising treatment strategy after MI.

79 One treatment strategy after orchiectomy is adjuvant chemoth

80 ting alpha2delta2 with a clinically relevant treatment strategy aids repair of motor circuits after S

81 While most treatment strategies aim to prevent neuronal loss or pro

82 which may be an important consideration for treatment strategies aiming to ameliorate this response

83 on, and open new avenues for archetype-based treatment strategies and clinical trials optimization.

84 stematically review the literature to assess treatment strategies and outcomes.

85 ssential tool for the proper use of invasive treatment strategies and patient prognostication.

86 estigate the association between neoadjuvant treatment strategy and perioperative complications in pa

87 ciated with leukemic transformation, current treatment strategies, and emerging therapeutic options f

88 the temporal trends, clinical presentation, treatment strategies, and in-hospital outcomes of patien

89 n, guiding individual patient management and treatment strategies, and informing infection prevention

90 rogression over 4 years, association between treatment strategies, and number of injections.

91 yocardial infarction, diagnostic evaluation, treatment strategies, and postevent care is necessary wh

92 cuses on conventional drug therapies, recent treatment strategies, and unique therapeutic approaches

93 Several treatment strategies are available that can successfully

94 y, alternative theranostic radionuclides and treatment strategies are discussed.

95 Appropriate drug treatment strategies are informed by diagnostics that es

96 rimarily on supportive measures, as specific treatment strategies are lacking.

97 prevalent Koos VI), microsurgery or combined treatment strategies are mostly recommended.

98 urvival in metastatic melanoma; however, new treatment strategies are needed to improve patients' out

99 in some countries, effective diagnostic and treatment strategies are needed to minimise the negative

100 revention of risk factors and improved acute treatment strategies are needed to reduce disparities in

101 ield unsatisfactory outcomes, and additional treatment strategies are needed.

102 As a consequence, treatment strategies are not well established.

103 igate whether school-based or community-wide treatment strategies are required for achieving the EPHP

104 d the amyloid cascade, indicating that novel treatment strategies are required.

105 Several treatment strategies are under development; however, sen

106 Therefore, treatment strategies are urgently needed to reverse the

107 Here, we discuss how nanomedicine-based treatment strategies are well suited to immunotherapy on

108 ancer might derive greater benefit from this treatment strategy as compared with PIK3CA WT patients w

109 onformity by covering current diagnostic and treatment strategies, as well as unmet needs and areas o

110 An adaptive treatment strategy (ATS) consists of personalized treatm

111 n receptor (AR) in HCC and tried to find new treatment strategy based on antiandrogen enzalutamide (E

112 therapy (alpha-RIT) represents an attractive treatment strategy because of the high-linear-energy tra

113 Immunotherapy is a powerful treatment strategy being applied to cancer, autoimmune d

114 0100), a prediction which is significant for treatment strategies but currently cannot be achieved by

115 inhibition of GBM progression and effective treatment strategies by targeting NRP-1 in addition to c

116 opment of novel drugs and improvement of the treatment strategy by implementing personalized medicine

117 All three treatment strategies can be recommended in the managemen

118 ies; thus, the use of inexpensive wastewater treatment strategies can help minimize this issue.

119 s demonstrate that a serological testing and treatment strategy could reduce P. vivax prevalence by 5

120 the acronym 'PRIME' to organize the various treatment strategies currently undergoing evaluation in

121 mended, which may be supplemented with other treatment strategies depending on the severity.

122 Hence, the optimal treatment strategy depends on setting-specific factors s

123 Two major treatment strategies employed in non-small cell lung can

124 Although water treatment strategies, failure to follow regulations, and

125 T cells are responsible for relapse, and new treatment strategies focus on eliminating these cells to

126 Designing personalized treatment strategies for AD is challenging, given the ap

127 this study, we aimed to investigate optimal treatment strategies for advanced stage disease in areas

128 concepts for B-cell-targeted prevention and treatment strategies for allergic asthma.

129 g in cancer can lead to the discovery of new treatment strategies for breast cancer subtypes that cur

130 unclear, impeding the implementation of new treatment strategies for cancer prevention and therapy.

131 to start treatment; evaluation of different treatment strategies for children with high rates of HBV

132 However, treatment strategies for congenital CMV (cCMV) infection

133 Drug-coated balloons (DCBs) are accepted treatment strategies for coronary in-stent restenosis an

134 nformation is being leveraged to develop new treatment strategies for CVD and may inform how periodon

135 esearch on biomarker-driven synthetic lethal treatment strategies for different cancers.

136 privation and the information for developing treatment strategies for disc degeneration.

137 patient stratification and immunotherapeutic treatment strategies for Elf5(low) patients with TNBC.

138 ear, presents an attractive target to study treatment strategies for genetic hearing loss and inner

139 ide insight useful in the development of new treatment strategies for gynecologic cancers.

140 variations, which will in turn inform better treatment strategies for implicated disorders.

141 designing better preventive, diagnostic, and treatment strategies for improved heart function.

142 nt trials will be needed to identify optimal treatment strategies for indirect TON.

143 due to their potential as a source for novel treatment strategies for kidney disease.

144 re needed to inform effective prevention and treatment strategies for leukaemia predisposition in pat

145 ocular examinations, imaging modalities, and treatment strategies for management of this spectrum of

146 These findings should be used to improve treatment strategies for MOG antibody-associated disorde

147 temozolomide, with the potential to improve treatment strategies for mutant IDH1 patients.

148 ng modifiable risk factors and informing new treatment strategies for neuropsychiatric disease.

149 ally precise stimulation could lead to novel treatment strategies for neuropsychiatric disorders invo

150 This insight could lead to new treatment strategies for new-onset diabetes and may have

151 ental CM and have implications in developing treatment strategies for organ-specific fatal malaria.

152 underlying pain in EAE and suggest potential treatment strategies for pain relief in MS.

153 rrently represents one of the most important treatment strategies for patients with advanced chronic

154 ingly, discovering and developing new potent treatment strategies for patients with metastatic prosta

155 ver may shed light on the development of new treatment strategies for patients with temporal lobe epi

156 critical to implement optimal prevention and treatment strategies for patients with these comorbiditi

157 cokinetic information needed to develop safe treatment strategies for pregnant and breastfeeding wome

158 y approaches, should enable new personalized treatment strategies for primary brain malignancies and

159 therapies appear to provide novel and safer treatment strategies for refractory ITx rejection; with

160 Thus, we increasingly use personalized treatment strategies for the recipient of an allograft w

161 However, optimal evaluation and treatment strategies for these etiologically distinct di

162 eceptors, is useful for developing potential treatment strategies for these neurological diseases.

163 t into this process while revealing rational treatment strategies for these patients.

164 ology, and facilitate the development of new treatment strategies for this debilitating disease of th

165 pancreatic cancer continues to increase, new treatment strategies for this devastating disease are ur

166 rivation therapy (ADT) has become a standard treatment strategy for advanced PCa.

167 a universal, artemisinin-based antimalarial treatment strategy for all Plasmodium species.

168 N status and can be used to optimize current treatment strategy for breast cancer patients.

169 ween 7 and 9 months appears to be reasonable treatment strategy for children without recurrent infect

170 ve as therapeutic targets in a comprehensive treatment strategy for chronic GI diseases.

171 s and discuss the potential use of IFNs as a treatment strategy for COVID-19.

172 peutics could eventually form the basis of a treatment strategy for illnesses that are linked to chro

173 regarding the optimal therapy selection and treatment strategy for individual patients, which might

174 tion, for incorporation into the overarching treatment strategy for infants undergoing lung transplan

175 ing hyperglycemia in diabetes as a causative treatment strategy for late diabetic complications and c

176 RIC is a viable and non-invasive treatment strategy for NEC.

177 Bariatric surgery should be considered as a treatment strategy for otherwise eligible patients with

178 Waiting for DND SLKT was the preferred treatment strategy for patients with a MELD score of 30

179 mbination with tumor ablation is a potential treatment strategy for patients with advanced BTC.

180 lmonary vein isolation (PVI) is an effective treatment strategy for patients with atrial fibrillation

181 tors FXR and TGR5 represents a new potential treatment strategy for patients with CDI.

182 ost function of the mutant transporters as a treatment strategy for patients with EIEE25.

183 lear p53 pathways and identifies a potential treatment strategy for patients with high-risk neuroblas

184 of drug-eluting stents (DES) is the dominant treatment strategy for patients with symptomatic coronar

185 ression of IL17RA is a promising new topical treatment strategy for psoriasis.

186 that anti-inflammatory drugs might be a new treatment strategy for PTSD.

187 inhibition of TNAP might provide a promising treatment strategy for PXE, a currently intractable dise

188 ubpopulations could therefore be a potential treatment strategy for RA.

189 it is of potential concern that our current treatment strategy for SAM regardless of HIV status invo

190 ific treatment, has become the main proposed treatment strategy for the clinical management of HCC, p

191 se and PARP inhibitors might be an effective treatment strategy for this deadly disease.

192 These findings reveal a potential novel treatment strategy for those cases of human nephrotic sy

193 nistration (MDA), the recommended antibiotic treatment strategy for trachoma's elimination as a publi

194 The optimal treatment strategy for treating ST-segment-elevation myo

195 -compulsive disorder is a rapidly developing treatment strategy for treatment-refractory patients.

196 eta and gammadelta T cells and may present a treatment strategy for tumors resistant to existing immu

197 py (ASI) has been proposed as an alternative treatment strategy for type 1 diabetes (T1D).

198 nical cutoff, resulting into a change of the treatment strategy from medical therapy to percutaneous

199 an 12 months after diagnosis, and a standard treatment strategy has not yet been established.

200 Prophylaxis and treatment strategies have been implemented as standard o

201 The shifting paradigm of diagnostic and treatment strategies holds significant promise to reduce

202 echanisms will hopefully allow us to improve treatment strategies in acute and chronic pancreatitis.

203 S double barrier system has implications for treatment strategies in both the acute and chronic phase

204 ns for rational escalation and de-escalation treatment strategies in HER2-positive breast cancer.

205 l research of pathobiological mechanisms and treatment strategies in HFpEF was discussed as an exampl

206 the possibility of NRF2 activators as future treatment strategies in keratoconus.

207 ning the MSLN-TTC with DDR inhibitors as new treatment strategies in MSLN-positive ovarian cancer.

208 ion as potential targets for anti-metastatic treatment strategies in osteosarcoma.

209 k of reactivation of TB due to HIV to inform treatment strategies in patients with M. tuberculosis/HI

210 ting long-term health outcomes and assessing treatment strategies in people with reduced kidney funct

211 cal trials to test genome-based personalized treatment strategies in PSC-BTC.

212 of RET alterations and the state-of-the-art treatment strategies in RET-dependent cancers.

213 the p38MAPK pathway may represent a crucial treatment strategy in alleviating hemolytic diseases.

214 genotype is important for the diagnostic and treatment strategy in IPD.

215 CRT may be a highly effective treatment strategy in mrTD/mrEMVI positive patients.

216 SCFAs, which may promote the development of treatment strategy in nephrolithiasis.

217 ster (KE) supplementation as a prevention or treatment strategy in rodent heart failure models.

218 Usual care with PPCI remains the appropriate treatment strategy in the majority of cases presenting w

219 Treatment strategies include the use of diuretics to rel

220 In addition, awareness of treatment strategies including the many hearing device o

221 ral anticoagulation after successful TAVR, a treatment strategy including rivaroxaban at a dose of 10

222 important complication of HCM, contemporary treatment strategies, including ICDs and heart transplan

223 prove diagnostic acumen worldwide and refine treatment strategies, including with anti-VEGF agents, t

224 We employed an alternative treatment strategy involving fractionated partial brain

225 surviving such an infection and the optimal treatment strategy is contentious.

226 ROs), to determine net clinical benefit of a treatment strategy is needed because of the substantial

227 Toward this end, an efficient NH(3) thermal-treatment strategy is presented for thoroughly removing

228 rm of valve disease where the only available treatment strategy is surgical valve replacement.

229 Now, a simple yet robust acid-treatment strategy is used to judiciously create an amor

230 s hampered the development of prevention and treatment strategies leading to the high morbidity and m

231 erapy stop, which makes the effectiveness of treatment strategies limited.

232 However, the trial was stopped early and no treatment strategy met prespecified criteria for statist

233 ve infections due to OUD, we compared 4 MOUD treatment strategies: methadone, buprenorphine, methadon

234 Prevention and treatment strategies might substantially reduce snakebit

235 l models may allow for better prevention and treatment strategies of EV-D68 CNS disease.

236 ules, have been increasingly integrated into treatment strategies of severe asthma.

237 essment as well as monitoring of neoadjuvant treatment strategies of STS.

238 acceptable morbidity were achieved with the treatment strategy of the choice of specific approaches

239 We quantified the impact of different STEMI treatment strategies on patient outcomes and provider ri

240 ic valve replacement; however, the effect of treatment strategy on health status is unknown.

241 d trial compared clinical effectiveness of 3 treatment strategies over 3 y for managing dental caries

242 ssion will contribute to the design of novel treatment strategies preventing HIV-1 dissemination.

243 elected patients, whereas in others the best treatment strategy probably involves a multimodal approa

244 e chemotherapy is the standard of care, this treatment strategy provides only modest survival benefit

245 toring technologies, and the optimization of treatment strategies, ranging from stroke prophylaxis to

246 ficile infections (CDI), which evade current treatment strategies, reflects the changing biology of C

247 Current treatment strategies rely on intensive glucose lowering

248 Prevention and treatment strategies rely on periodic mass drug administ

249 ajor health concern for which prevention and treatment strategies remain elusive.

250 energy expenditure (EE), and prevention and treatment strategies remain generally ineffective.

251 g cause of disability worldwide, yet current treatment strategies remain limited in their mechanistic

252 athogenesis-, stage-, and cell type-specific treatment strategies require refined dissection of the e

253 All treatment strategies resulted in significant improvement

254 Present findings support that mechanical treatment strategies selected for implant biofilm remova

255 Treatment strategies should be customized for each indiv

256 tion and management of MDD is important, and treatment strategies should be selected to also minimise

257 sions at the end or during a trial, for many treatment strategies, simultaneously.

258 More-effective treatment strategies still are needed for infants with u

259 may contribute to the development of future treatment strategies targeting these pathomechanisms.

260 This effect is clearly different from other treatment strategies tested to date, in that the drug sh

261 ased medicine with detection, diagnosis, and treatment strategies that are continuously adapted to in

262 and could inform the design of personalized treatment strategies that can be tested in future studie

263 ns the possibility of identifying new cancer treatment strategies that combine vascular targeting and

264 ug response in order to develop personalized treatment strategies that maximize therapeutic efficacy

265 open new avenues to creating diagnostic and treatment strategies that may slow the aging process bas

266 could inform the design of new combinatorial treatment strategies that might be more efficacious than

267 This in turn leads to potential treatment strategies that pave the way to precision medi

268 otential candidates for molecularly targeted treatment strategies that will need to be evaluated in f

269 to inhibit viral replication is a potential treatment strategy that avoids development of antiviral

270 Overall, this is an innovative and optimized treatment strategy that has a potential for therapeutic

271 Cancer immunotherapy is an emerging treatment strategy that modulates the immune system to f

272 approach guides an effective individualized treatment strategy that results in rapid sustained cultu

273 Here, we describe a novel treatment strategy that targets cyclin-dependent kinase

274 We test a treatment strategy that targets the dichotomous function

275 standing of these mechanisms and develop new treatment strategies, there is a renewed interest in inv

276 ing mechanisms may help identify targets and treatment strategies to benefit patients.

277 Thus, treatment strategies to combat metabolic dysfunction are

278 d can be employed to identify mechanisms and treatment strategies to improve patient care.

279 he Haemophilus-high group might benefit from treatment strategies to modulate the airway ecology warr

280 types, and tested potential pharmacological treatment strategies to retard its progression in vivo.

281 Triac seems a reasonable treatment strategy to ameliorate the consequences of unt

282 glion cells; lowering IOP is the only proven treatment strategy to delay disease progression.

283 ncer cells and position mTOR inhibition as a treatment strategy to target CSCs.

284 n, even when the latter is resistant to drug treatment, strategies to screen patients for PA early wi

285 Insulin treatment strategies vary significantly, irrespective of

286 evaluate surgical candidacy and/or to define treatment strategies was developed.

287 Interaction with index treatment strategy was assessed.

288 A novel triphenylphosphine (TPP) treatment strategy was developed to prepare the near-inf

289 In pursuing this potential treatment strategy, we found that Tim-3 (often associate

290 Combination treatment strategies were more likely to be implemented

291 n, laboratory values, immunosuppression, and treatment strategies were reviewed, and predictors of po

292 tegory 2 nodules was compared, and different treatment strategies were tested (stereotactic body radi

293 rventions were calculated, and predictors of treatment strategy were evaluated in multivariable multi

294 , and the reluctance of physicians to modify treatment strategies when BP is still elevated, that is,

295 Methods for estimating optimal adaptive treatment strategies, which must disentangle short- and

296 This treatment strategy will help to avoid the risks of surge

297 latform and software package for combination treatment strategies with flexible pharmacokinetic profi

298 latform and software package for combination treatment strategies with flexible pharmacokinetic profi

299 onstrated no association between T&E and PRN treatment strategies with the risk of new MA developing

300 Seventy-five mice underwent a prevention treatment strategy with a KE comprised of hexanoyl-hexyl